The SOUL Clinical Trial The SOUL trial was a landmark phase 3b, randomized, double blind, placebo controlled cardiovascular outcomes trial that evaluated oral semaglutide in 9,650 adults with type 2 diabetes and established atherosclerotic cardiovascular disease, chronic kidney disease, or both
Just because GLP-1 medications arent the best choice for PCOS doesnt mean youre stuck with your symptoms and weight gain
Multivariate analysis showed no difference between placebo and liraglutide arms in HbA1c at 6 months (HbA1c:0.2 mmol/mol, 11.3, 11.6, p = 0.98) however, at 12 months HbA1c was significantly higher in the liraglutide arm (HbA1c:10.9 mmol/mol, 1.1, 20.6, p = 0.032)
RosenstockJBuseJBAzeemRPrabhakarPKjemsLHuangHet al
Desarrollados originalmente para controlar los niveles de azcar en sangre, estos medicamentos son ahora ampliamente conocidos por favorecer la prdida de peso